These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1141 related items for PubMed ID: 27574421

  • 1. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base.
    Li F, Zheng C, Xin J, Chen F, Ling H, Sun L, Webster TJ, Ming X, Liu J.
    Int J Nanomedicine; 2016; 11():3875-90. PubMed ID: 27574421
    [Abstract] [Full Text] [Related]

  • 2. pH-sensitive Au-BSA-DOX-FA nanocomposites for combined CT imaging and targeted drug delivery.
    Huang H, Yang DP, Liu M, Wang X, Zhang Z, Zhou G, Liu W, Cao Y, Zhang WJ, Wang X.
    Int J Nanomedicine; 2017; 12():2829-2843. PubMed ID: 28435261
    [Abstract] [Full Text] [Related]

  • 3. Folate-receptor mediated pH/reduction-responsive biomimetic nanoparticles for dually activated multi-stage anticancer drug delivery.
    Wang D, Chen W, Li H, Huang G, Zhou Y, Wang Y, Wan W, You B, Liu Y, Zhang X.
    Int J Pharm; 2020 Jul 30; 585():119456. PubMed ID: 32492507
    [Abstract] [Full Text] [Related]

  • 4. Engineered bovine serum albumin-based nanoparticles with pH-sensitivity for doxorubicin delivery and controlled release.
    Yang Z, Zhang N, Ma T, Liu L, Zhao L, Xie H.
    Drug Deliv; 2020 Dec 30; 27(1):1156-1164. PubMed ID: 32755291
    [Abstract] [Full Text] [Related]

  • 5. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.
    Qi WW, Yu HY, Guo H, Lou J, Wang ZM, Liu P, Sapin-Minet A, Maincent P, Hong XC, Hu XM, Xiao YL.
    Mol Pharm; 2015 Mar 02; 12(3):675-83. PubMed ID: 25584860
    [Abstract] [Full Text] [Related]

  • 6. Doxorubicin-Bound Albumin Nanoparticles Containing a TRAIL Protein for Targeted Treatment of Colon Cancer.
    Thao le Q, Byeon HJ, Lee C, Lee S, Lee ES, Choi YW, Choi HG, Park ES, Lee KC, Youn YS.
    Pharm Res; 2016 Mar 02; 33(3):615-26. PubMed ID: 26526555
    [Abstract] [Full Text] [Related]

  • 7. EGFR Targeted Cetuximab-Valine-Citrulline (vc)-Doxorubicin Immunoconjugates- Loaded Bovine Serum Albumin (BSA) Nanoparticles for Colorectal Tumor Therapy.
    Ye Z, Zhang Y, Liu Y, Liu Y, Tu J, Shen Y.
    Int J Nanomedicine; 2021 Mar 02; 16():2443-2459. PubMed ID: 33814909
    [Abstract] [Full Text] [Related]

  • 8. Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery.
    Zu Y, Meng L, Zhao X, Ge Y, Yu X, Zhang Y, Deng Y.
    Int J Nanomedicine; 2013 Mar 02; 8():1207-22. PubMed ID: 23569373
    [Abstract] [Full Text] [Related]

  • 9. BSA-based Cu2Se nanoparticles with multistimuli-responsive drug vehicles for synergistic chemo-photothermal therapy.
    Liu Z, Chan L, Ye X, Bai Y, Chen T.
    Colloids Surf B Biointerfaces; 2018 Dec 01; 172():298-307. PubMed ID: 30173097
    [Abstract] [Full Text] [Related]

  • 10. Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin.
    Chen WL, Li F, Tang Y, Yang SD, Li JZ, Yuan ZQ, Liu Y, Zhou XF, Liu C, Zhang XN.
    Int J Nanomedicine; 2017 Dec 01; 12():4241-4256. PubMed ID: 28652730
    [Abstract] [Full Text] [Related]

  • 11. Nuclear-targeting TAT-PEG-Asp8-doxorubicin polymeric nanoassembly to overcome drug-resistant colon cancer.
    Pan ZZ, Wang HY, Zhang M, Lin TT, Zhang WY, Zhao PF, Tang YS, Xiong Y, Zeng YE, Huang YZ.
    Acta Pharmacol Sin; 2016 Aug 01; 37(8):1110-20. PubMed ID: 27292613
    [Abstract] [Full Text] [Related]

  • 12. Biocompatibility studies of intravenously administered ionic-crosslinked chitosan-BSA nanoparticles as vehicles for antitumour drugs.
    Montero N, Pérez E, Benito M, Teijón C, Teijón JM, Olmo R, Blanco MD.
    Int J Pharm; 2019 Jan 10; 554():337-351. PubMed ID: 30439492
    [Abstract] [Full Text] [Related]

  • 13. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery.
    Lee JY, Chung SJ, Cho HJ, Kim DD.
    Eur J Pharm Biopharm; 2015 Aug 10; 94():532-41. PubMed ID: 26149228
    [Abstract] [Full Text] [Related]

  • 14. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
    Zhang X, Wang Q, Qin L, Fu H, Fang Y, Han B, Duan Y.
    Drug Deliv; 2016 Oct 10; 23(8):2936-2945. PubMed ID: 26739487
    [Abstract] [Full Text] [Related]

  • 15. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas.
    Su Z, Xing L, Chen Y, Xu Y, Yang F, Zhang C, Ping Q, Xiao Y.
    Mol Pharm; 2014 Jun 02; 11(6):1823-34. PubMed ID: 24779677
    [Abstract] [Full Text] [Related]

  • 16. In vitro evaluation of doxorubicin-incorporated magnetic albumin nanospheres.
    Zeybek A, Şanlı-Mohamed G, Ak G, Yılmaz H, Şanlıer ŞH.
    Chem Biol Drug Des; 2014 Jul 02; 84(1):108-15. PubMed ID: 24524300
    [Abstract] [Full Text] [Related]

  • 17. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
    He Y, Su Z, Xue L, Xu H, Zhang C.
    J Control Release; 2016 May 10; 229():80-92. PubMed ID: 26945977
    [Abstract] [Full Text] [Related]

  • 18. 99mTc-doxorubicin-loaded gallic acid-gold nanoparticles (99mTc-DOX-loaded GA-Au NPs) as a multifunctional theranostic agent.
    El-Ghareb WI, Swidan MM, Ibrahim IT, Abd El-Bary A, Tadros MI, Sakr TM.
    Int J Pharm; 2020 Aug 30; 586():119514. PubMed ID: 32565281
    [Abstract] [Full Text] [Related]

  • 19. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
    Feng C, Wang Z, Jiang C, Kong M, Zhou X, Li Y, Cheng X, Chen X.
    Int J Pharm; 2013 Nov 30; 457(1):158-67. PubMed ID: 24029170
    [Abstract] [Full Text] [Related]

  • 20. Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug.
    Lee BS, Park K, Park S, Kim GC, Kim HJ, Lee S, Kil H, Oh SJ, Chi D, Kim K, Choi K, Kwon IC, Kim SY.
    J Control Release; 2010 Oct 15; 147(2):253-60. PubMed ID: 20624433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.